NCT01883063

Brief Summary

This is a prospective multi-site study. Subjects with distal radius fractures will be enrolled. Subjects will be treated surgically with a Sonoma WRx™ device or managed non-operatively with a splint or cast. Subjects will be enrolled in each group according to physician's standard of care (either casting/splinting or surgery) for distal radius fractures. Subjects will be enrolled based on the study's inclusion/exclusion criteria with a final qualifying decision made by a group of three independent adjudicators. The final qualifying review should allow for similar patient groups within each arm of the study due to the variability that can arise in fracture classification. Review by the adjudicators should be completed within 1 week.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
9

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2013

Geographic Reach
1 country

3 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 14, 2013

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 21, 2013

Completed
10 days until next milestone

Study Start

First participant enrolled

July 1, 2013

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2014

Completed
Last Updated

April 14, 2015

Status Verified

April 1, 2015

Enrollment Period

1.4 years

First QC Date

June 14, 2013

Last Update Submit

April 12, 2015

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Composite Patient Outcomes Over Time

    Patient outcomes will be measured with the DASH, PRWE and a patient questionnaire.

    Data will be collected at 2, 6, 12, 26, 52 weeks

Secondary Outcomes (1)

  • Change in Composite Functional Outcomes Over Time

    Data will be collected at 2, 6, 12, 26, 52 weeks

Study Arms (2)

WRx™ Intramedullary Nail

EXPERIMENTAL

Patients in this arm of the study will be treated with a minimally invasive WRx™ Intramedullary Nail for their wrist fracture.

Device: Surgical Treatment

Non surgical treatment (Cast)

ACTIVE COMPARATOR

Patients in this arm of the study will be treated with a cast for their wrist fracture.

Device: Non surgical Treatment (Cast or splint)

Interventions

Patients will be treated for distal radius fractures surgically with a WRx™ Intramedullary Nail

WRx™ Intramedullary Nail

Patients will be treated for distal radius fractures non surgically with a cast or splint

Non surgical treatment (Cast)

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • Closed extra-articular distal radius fracture or a minimally displaced intra-articular fracture
  • Fracture classified as an AO/OTA A2, A3, C1 or C2 with or without an ulnar styloid fracture
  • Must be treated within the first 14 days of injury,
  • Male or female greater than or equal to 65 years of age.
  • Able to understand the requirements of the study, provide a written informed consent and comply with the study protocol
  • Ability to understand and provide written authorization for use and disclosure of personal health information
  • Fracture that can be treated closed with or without closed reduction

You may not qualify if:

  • Concomitant contralateral or ipsilateral upper extremity fractures
  • Ipsilateral ulna (excluding styloid) fracture
  • Open fracture
  • Previous ipsilateral distal radius fracture in the 2 years prior to enrollment with deformity
  • Unstable distal radioulnar joint after fracture fixation
  • Fractures where the transverse fracture line is less than 10mm from the distal radius joint surface
  • Artery or Nerve injury secondary to fracture
  • History of alcoholism
  • Currently on chemotherapy or radiation therapy
  • Currently on worker's compensation
  • Rheumatoid arthritis or other inflammatory arthropathies.
  • History of chronic pain issues or psychiatric disorder that precludes reliable follow-up.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Cadence Health

Winfield, Illinois, 60190, United States

Location

University of Missouri

Columbia, Missouri, 65211, United States

Location

John Peter Smith Hospital

Fort Worth, Texas, 76107, United States

Location

MeSH Terms

Interventions

Surgical Procedures, OperativeSplints

Intervention Hierarchy (Ancestors)

External FixatorsOrthopedic Fixation DevicesOrthopedic EquipmentSurgical EquipmentEquipment and SuppliesSurgical Fixation Devices

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 14, 2013

First Posted

June 21, 2013

Study Start

July 1, 2013

Primary Completion

December 1, 2014

Study Completion

December 1, 2014

Last Updated

April 14, 2015

Record last verified: 2015-04

Locations